Media Release

Dr Kelvin Loh, Interim Chief Executive Officer of GHK (second right), Mr Rufin Mak, Executive Director of NWS Holdings (second left), Mr Lee Cheow Seng, Deputy Chief Executive Officer of GHK (far right) and Dr Alexander Chiu, Chief Operating Officer of GHK (far left)

(13 February 2017 – Hong Kong)      Dedicated to delivering excellent healthcare services for Hong Kong people, Gleneagles Hong Kong Hospital (GHK) will be the first private hospital to provide at least 51% of inpatient bed days at packaged rates, with 70% of the bed days set aside for local residents. At the initial stage, GHK will provide 50 medical packages when it opens. All packages are fixed-price and all-inclusive in nature, and fee advisory services will be offered to all patients before admission to help patients better manage costs and make informed decisions.

The standard packages cover procedures in ENT (eye, nose, throat), endoscopy, general surgery, gynaecology, ophthalmology, orthopaedic and urology. These packages will start from the price of HK$13,180. Wherever appropriate, packages offer different surgical and equipment options to meet different patients’ needs and conditions.

“The standard packages will initially focus on commonly encountered clinical conditions with long waiting time. We aim to progressively increase the number of packages to 150 that can cater for more critical conditions such as cancer and heart diseases,” says Dr Kelvin Loh, Interim Chief Executive Officer of GHK. “Medical package is a relatively new concept in Hong Kong, we will continue to review and refine the model to meet patients’ needs.”

Mr Rufin Mak, Executive Director of NWS Holdings, says, “GHK is committed to offering excellent healthcare services and care to patients and users. We consider it equally important to provide a comfortable and user-friendly environment. The hospital is architecturally designed not only to optimise accessibility and operational functionality but also offer a warm and healing environment, reflecting our vision of building a top-notch private hospital in Hong Kong.”

The clinical criteria for GHK’s medical packages are developed in consultation with Li Ka Shing Faculty of Medicine of The University of Hong Kong (“HKU”), which oversees GHK’s clinical governance as its exclusive clinical partner. Treatment options, patient selection criteria and lengths of stay are based on input from clinical experts, supported by scientific evidence whenever appropriate. HKU is not responsible for setting prices or costing of the packages.

The all-inclusive packages include doctor’s fee, room charges, diagnostic procedures, treatment procedures, operating theatre charges, anaesthetic fees, nursing care, medications, equipment charges, consumables, implants and meals. Packages will also allow for complications that may require re-operation and intensive care within the prescribed length of stay.

To provide more option to patients, GHK will also offer an extension package to be charged on a per day basis for patients who opts to stay longer. Extension packages are also all-inclusive in nature, with the exception of services such as re-operation and intensive care.

GHK will provide quotations on packaged services and advise patients on any additional charges before proceeding with any services or procedures. Items that are excluded from the package fee will be stated clearly on the quotation. The full list of packages and their prices will be available on the hospital website.

Gleneagles Hong Kong Hospital

Located at Wong Chuk Hang on Hong Kong Island South, Gleneagles Hong Kong Hospital (GHK) will provide 500 beds, cutting-edge medical technologies and a comprehensive range of clinical services spanning more than 35 specialties and subspecialties. As Hong Kong’s top-notch private teaching hospital, GHK will also contribute to the training and development of healthcare professionals and advancement of clinical research.

GHK is a partnership between Parkway Pantai and NWS Holdings with the participation of Li Ka Shing Faculty of Medicine of The University of Hong Kong as the exclusive clinical partner.

Parkway Pantai Limited

Parkway Pantai is one of Asia’s largest integrated private healthcare groups operating in Singapore, Malaysia, India, China, Brunei and United Arab Emirates. For over 40 years, its Mount Elizabeth, Gleneagles, Pantai and Parkway brands have established themselves as the region’s best known brands in private healthcare, synonymous with best-in-class patient experience and outcomes.

Leveraging its global track record for medical excellence and managing world-class hospitals, Parkway Pantai is committed to making a difference in people’s lives through excellent patient care, steadily expanding its reach in markets where demand for quality care is strong and growing.

Parkway Pantai is a leading healthcare player in its home markets of Singapore, Malaysia and India and key growth markets of China and Hong Kong. It is part of IHH Healthcare, the world’s second largest healthcare group by market capitalisation. IHH operates more than 10,000 licensed beds across 52 hospitals in 10 countries worldwide, offering the full spectrum of integrated healthcare services from clinics to hospitals to quaternary care and a wide range of ancillary services including medical education.

NWS Holdings Limited

NWS Holdings Limited (“NWS Holdings”, Hong Kong stock code: 659) is the infrastructure and service flagship of New World Development Company Limited (Hong Kong stock code: 17). It has diverse businesses and investments predominantly in Hong Kong and Mainland China, comprising toll roads, environmental management, port and logistics facilities, rail container terminals, commercial aircraft leasing, facilities management, healthcare services, construction and public transport. Please visit www.nws.com.hk for details.

Li Ka Shing Faculty of Medicine of The University of Hong Kong

The Medical Faculty of The University of Hong Kong (HKU) is the longest established institution in higher education of Hong Kong.  It was founded as the Hong Kong College of Medicine in 1887 and was renamed as the Hong Kong College of Medicine in 1907.  The Faculty was deemed as the premier Faculty when the University was established in 1911.  From its modest beginning, the Faculty has now become the largest faculty of the University, with over 400 full-time academic and academic-related staff and 800 research and research-related support personnel. The undergraduate student population is about 2,900 and the postgraduate student population is about 1,500.  The Faculty is comprised of 14 departments, School of Biomedical Sciences, School of Chinese Medicine, School of Nursing, School of Public Health and a number of research centres focusing on various strengths of research.